
The episode discusses the modernization of pathology labs in Australia and the Asia-Pacific region, focusing on the challenges and opportunities presented by technology and workforce shortages.
In this episode of Talking HealthTech, Peter Birch sits down with Dan Burke, Managing Director at Magentus, and Ben Richardson, CEO at Labflow, for a wide-ranging conversation about the state of pathology in Australia and the broader Asia-Pacific region. With half a billion pathology tests processed in Australia every year and a workforce of only 2,500 pathologists, the sector is under significant pressure. Dan and Ben unpack what that means for labs trying to modernise without disrupting the critical services that clinicians and patients depend on every day. The discussion covers the growing role of artificial intelligence in diagnostic settings, exploring where AI is already delivering practical value and where human oversight remains non-negotiable. The episode also digs into the challenge of legacy technology, making the case for incremental, modular modernisation over risky large-scale overhauls that can put operations at risk. Beyond the technology, the conversation explores how consumer expectations are reshaping pathology, from the direct-to-consumer testing boom across Asia-Pacific markets to the rise of genomics and personalised medicine. Key Takeaways 🔬 The pathology…
Host: Peter Birch
Guests: Dan Burke, Ben Richardson
Organizations: Magentus, Labflow
Places: Australia, Asia-Pacific
Explore listener stats, chart rankings, contacts and more on the Talking HealthTech podcast page.